Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Journal of Neurology
|
July 15, 2025
Longitudinal evaluation of serum neurofilament light levels in normal healthy volunteers: defining a threshold of concern
Thomas A Lanz, Klemens Ruprecht, Christopher J Somps, et al.
Chemistry & Biology
|
December 17, 2015
Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities
Eugene L Piatnitski Chekler, Jessica A Pellegrino, Thomas A Lanz, et al.
Journal of Molecular Biology
|
December 27, 2011
Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease
Sherry L La Porte, Sangeetha Subbarao Bollini, Thomas A Lanz, et al.
Science Translational Medicine
|
July 27, 2018
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio, Eric K Hoffman, Emily M Rocha, et al.
Human Gene Therapy
|
December 21, 2021
Biodistribution and Tolerability of AAV-PHP.B-CBh-<i>SMN1</i> in Wistar Han Rats and Cynomolgus Macaques Reveal Different Toxicologic Profiles
Xavier Palazzi, Ingrid D Pardo, Madhu P Sirivelu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 6, 2010
Pharmacodynamics and pharmacokinetics of the gamma-secretase inhibitor PF-3084014
Thomas A Lanz, Kathleen M Wood, Karl E G Richter, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 22, 2006
Concentration-dependent modulation of amyloid-beta in vivo and in vitro using the gamma-secretase inhibitor, LY-450139
Thomas A Lanz, Michael J Karmilowicz, Kathleen M Wood, et al.
Nature Neuroscience
|
October 24, 2020
Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia
Gun-Hoo Park, Haneul Noh, Zhicheng Shao, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2026
Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuries
Stuart Astbury, Edmond Atallah, Jane I Grove, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 4, 2023
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6<sup>+</sup> T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
Wei Li, Kimberly K Crouse, Jennifer Alley, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Journal of Neurology
|
July 15, 2025
Longitudinal evaluation of serum neurofilament light levels in normal healthy volunteers: defining a threshold of concern
Thomas A Lanz, Klemens Ruprecht, Christopher J Somps, et al.
Chemistry & Biology
|
December 17, 2015
Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities
Eugene L Piatnitski Chekler, Jessica A Pellegrino, Thomas A Lanz, et al.
Journal of Molecular Biology
|
December 27, 2011
Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease
Sherry L La Porte, Sangeetha Subbarao Bollini, Thomas A Lanz, et al.
Science Translational Medicine
|
July 27, 2018
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio, Eric K Hoffman, Emily M Rocha, et al.
Human Gene Therapy
|
December 21, 2021
Biodistribution and Tolerability of AAV-PHP.B-CBh-<i>SMN1</i> in Wistar Han Rats and Cynomolgus Macaques Reveal Different Toxicologic Profiles
Xavier Palazzi, Ingrid D Pardo, Madhu P Sirivelu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 6, 2010
Pharmacodynamics and pharmacokinetics of the gamma-secretase inhibitor PF-3084014
Thomas A Lanz, Kathleen M Wood, Karl E G Richter, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 22, 2006
Concentration-dependent modulation of amyloid-beta in vivo and in vitro using the gamma-secretase inhibitor, LY-450139
Thomas A Lanz, Michael J Karmilowicz, Kathleen M Wood, et al.
Nature Neuroscience
|
October 24, 2020
Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia
Gun-Hoo Park, Haneul Noh, Zhicheng Shao, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2026
Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuries
Stuart Astbury, Edmond Atallah, Jane I Grove, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 4, 2023
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6<sup>+</sup> T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
Wei Li, Kimberly K Crouse, Jennifer Alley, et al.
Page
of 5